Literature DB >> 23623743

A comparative study of protein carbonylation and mitochondrial dysfunction using the neurotoxicants 1,3-dinitrobenzene, 3-nitropropionic acid, and 3-chloropropanediol.

Stephen R Steiner1, Evan Milton, Martin A Philbert.   

Abstract

This comparative evaluation of neurotoxicants previously identified as models of chemical-induced mitochondrial dysfunction and energy deprivation demonstrated that subtoxic concentrations of 1,3-dinitrobenzene (1,3-DNB), 3-nitropropionic acid (3-NPA), and 3-chloropropanediol (3-CPD) each led to concentration-dependent loss of the mitochondrial membrane potential (ΔΨm) associated with similar patterns of protein carbonylation. Subtoxic concentrations of each neurotoxicant were determined by measuring DI TNC1 cell viability using the MTS cell proliferation assay. Although exposure 1 μM, 10 μM, and 100 μM concentrations of each toxicant did not result in loss of cell viability after 48 h, exposure to each toxicant at these concentrations led to concentration-dependent loss of tetramethyl rhodamine methyl ester (TMRM) fluorescence over the same exposure period. Preincubation with the antioxidant, deferoxamine, was effective in preventing loss of TMRM flurorescence. Through the combined use of two-dimensional polyacrylamide gel electrophoresis (2D PAGE) and Oxyblot analysis, this study demonstrated that exposure to each toxicant resulted in the formation of distinctly similar patterns of protein carbonylation comprised of specific proteins identified with tandem MS/MS. Our results provide insight as to how exposure to different neurotoxicants that enhance oxidative stress may, in fact, lead to mitochondrial injury and subsequent toxicity through selective, yet shared, pathways of protein modification by oxidative carbonylation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623743      PMCID: PMC3696425          DOI: 10.1016/j.neuro.2013.04.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  42 in total

1.  Protein oxidation in the brain in Alzheimer's disease.

Authors:  M Y Aksenov; M V Aksenova; D A Butterfield; J W Geddes; W R Markesbery
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  1,3-dinitrobenzene: toxic effects in vivo and in vitro.

Authors:  T E Cody; S Witherup; L Hastings; K Stemmer; R T Christian
Journal:  J Toxicol Environ Health       Date:  1981-05

Review 3.  Mechanisms of injury in the central nervous system.

Authors:  M A Philbert; M L Billingsley; K R Reuhl
Journal:  Toxicol Pathol       Date:  2000 Jan-Feb       Impact factor: 1.902

4.  Differential cellular regulation of the mitochondrial permeability transition in an in vitro model of 1,3-dinitrobenzene-induced encephalopathy.

Authors:  R B Tjalkens; M M Ewing; M A Philbert
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

6.  1,3-Dinitrobenzene inhibits mitochondrial complex II in rat and mouse brainstem and cortical astrocytes.

Authors:  Amanda D Phelka; Melissa J Beck; Martin A Philbert
Journal:  Neurotoxicology       Date:  2003-06       Impact factor: 4.294

7.  Carbonylation of ER chaperone proteins in aged mouse liver.

Authors:  Jeffrey P Rabek; William H Boylston; John Papaconstantinou
Journal:  Biochem Biophys Res Commun       Date:  2003-06-06       Impact factor: 3.575

8.  Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact.

Authors:  Colin L Willis; Christopher C Nolan; Sharon N Reith; Timothy Lister; Malcolm J W Prior; Christopher J Guerin; George Mavroudis; David E Ray
Journal:  Glia       Date:  2004-03       Impact factor: 7.452

9.  Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts.

Authors:  Joungil Choi; Christina A Malakowsky; John M Talent; Craig C Conrad; Christopher A Carroll; Susan T Weintraub; Robert W Gracy
Journal:  Biochim Biophys Acta       Date:  2003-03-20

10.  Protein carbonylation and aggregation precede neuronal apoptosis induced by partial glutathione depletion.

Authors:  Anushka Dasgupta; Jianzheng Zheng; Oscar A Bizzozero
Journal:  ASN Neuro       Date:  2012-04-10       Impact factor: 4.146

View more
  3 in total

Review 1.  The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration.

Authors:  Laura L Kubik; Martin A Philbert
Journal:  Toxicol Sci       Date:  2015-03       Impact factor: 4.849

2.  1,3-dinitrobenzene induces age- and region-specific oxidation to mitochondria-related proteins in brain.

Authors:  Laura L Kubik; Rory W Landis; Henriette Remmer; Ingrid L Bergin; Martin A Philbert
Journal:  Toxicol Sci       Date:  2015-02-24       Impact factor: 4.849

3.  PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.

Authors:  Aleksandra Dabrowska; Jose Luis Venero; Ryota Iwasawa; Mohammed-Khair Hankir; Sunniyat Rahman; Alan Boobis; Nabil Hajji
Journal:  Aging (Albany NY)       Date:  2015-09       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.